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http:WHAT THIS PAPER ADDS
The role of the intraluminal thrombus (ILT) is still heavily debated with regard to whether it accelerates growth
or is simply a passive bystander. This large prospective cohort study reveals unique information about patients
with abdominal aortic aneurysms (AAA) and the possible interactions between the AAA and the ILT. There
appears to be a weak, yet signiﬁcant, correlation between the initial thrombus size and an increased growth
rate, but whether the ILT is harmful, protective, or both remains unclear.Objective: To investigate whether the relative size of intraluminal thrombus (ILT) in abdominal aortic aneurysms
(AAAs) is associated with AAA growth.
Methods: This large observational study was based on a randomised population-based screening trial. Six
hundred and ﬁfteen AAAs were diagnosed in men aged 65e74 years. The relative cross-sectional area covered by
the mural thrombus was estimated by a semiautomatic method using ultrasound equipment to measure the area
of the ellipses, and adapting the inner ellipse (IA) to the luminal border of the thrombus and the outer ellipse to
the area inside the media border (OA). The relative thrombus area was then calculated as ((OAeIA)/OU)  100%.
Four hundred and sixteen of the patients with AAA were eligible for analysis.
Results: The mean size of the AAA was 40.6 mm, and the mean observation time was 1.78 years. In the group
with AAAs measuring 30e34 mm, 42% had ILT, with a mean relative size of 12% of the outer area. In the
group with AAAs measuring >64 mm, the presence of ILT increased to 100%, with a mean relative size of
70% of the outer area. Univariate analysis showed relative ILT size, aortic diameter, smoking history, and
diastolic blood pressure were signiﬁcantly positively associated with growth rate, while the presence of
diabetes mellitus was signiﬁcantly negatively associated with growth rate. The relative ILT size remained
signiﬁcantly positively associated with the growth rate after a multivariate linear regression adjusting for
potential confounders.
Conclusion: These ﬁndings suggest that ILT may play a part in the progression of AAAs.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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In virtually any aneurysm of clinically important size, intra-
luminal thrombus (ILT) can be found.1,2 It is believed that
the ILT is a natural phenomenon that is based on the
deposition of blood components when an abdominal aortic
aneurysm (AAA) grows to a certain size. Whether the
presence of ILT has any inﬂuence on the natural history of
the AAA continues to be a matter of debate. It may be that
the ILT’s structural elastic integrity buffers the mechanical
stress on the AAA wall.3 Alternatively, it has been thoughtrresponding author.
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//dx.doi.org/10.1016/j.ejvs.2014.05.014that biologically active substances inﬁltrate through the
aortic wall by centrifugal convection and centripetal ﬁltra-
tion, destabilising the matrix-rich aortic media,4,5 increasing
the inﬂammatory response and therefore increasing the risk
of progression and rupture. The complex biological inter-
action between the ILT and the aortic wall appears to be
divided into layers. The biological activity in the bloodeILT
zone encourages platelet aggregation.5 Together with
endothelial injury, the platelets become activated by the
biomechanical circumstances occurring in the in-ﬂow part
of the AAA and are then deposited when released further
down in the aneurysm.6,7 Earlier experimental studies
suggested that the presence of ILT is associated with a
higher risk of accelerated growth and rupture.1,4,8 The two
latter complications are the major concerns among clini-
cians. A recent study looked at the association between the
AAA thrombus volume and cardiovascular events and AAA
Figure 1. Large abdominal aortic aneurysm in longitudinal view
showing anterior to posterior measurements.
302 C. Behr-Rasmussen et al.growth.9 Although a smaller study, the thrombus volume
showed a signiﬁcant association with both cardiovascular
events and AAA growth.
One component of the creation and growth of ILT relies
on platelets. Observational human-based studies suggest
that these complex interactions take place in the ILT of an
AAA,5 and small human cohort studies suggest a potential
beneﬁt of antiplatelet treatment of medium-sized AAAs.10
Nevertheless, the association between the role of ILT with
the progression of AAA is poorly understood. Several
diagnostic modalities have been used to try to describe the
association, each with its own strengths and drawbacks. In
this study, ultrasonography was chosen for its portability
and therefore its ability to screen a large number of
patients.
The aim of this study was to analyse whether ILT may be
an independent risk factor for the ongoing enlargement in
AAA diameter after adjusting for the other risk factors of
AAA growth.Figure 2. Same abdominal aortic aneurysm as in Fig. 1 in cross-
sectional view, visualising the large intraluminal thrombus, the
bloodeintraluminal thrombus interface and the central lumen.MATERIALS AND METHODS
In this prospective cohort study, data from the population-
based Viborg Vascular (VIVA) trial were used.11 More than
50,000 white men aged 65e74 years living in the Central
Denmark Region were randomised 1:1 using the Civil
Registration System registry either to receive an invitation
to vascular screening or to participate in a control group
(clinicaltrials.gov identiﬁer: NCT00662480). The control
group consisted of those not randomised for participation
because there was no current population-based screening
programme for AAA in Denmark during the study period.
The participation rate in the VIVA study was 75% (18,628/
25,065). From October 2008 until January 2011 trained
project nurses diagnosed 615 patients with an AAA
(30 mm) by abdominal ultrasound examination (Logiq E,
using a curved array probe 4C-RS with a 4-MHz setting; GE
Healthcare, Fairﬁeld, CT, USA). AAAs <50 mm in antero-
posterior diameter were followed up annually by ultra-
sound; AAAs >50 mm and those that showed progression
above 50 mm during the control visits were referred to a
vascular surgery department in the Central Denmark Region
for evaluation. Those growing rapidly were also followed up
until they were >50 mm and then referred. At the baseline
visit, informed consent was obtained from all those invited
before their participation. Only those who were randomised
to participate and agreed to join gave their written consent.
The study was approved by the local ethics committee
and the data protection authorities, and was performed in
accordance with the Declaration of Helsinki.
After diagnosing an AAA, an informative baseline
consultation was offered for information, interview, weight,
height, preventive actions (i.e., initiation of aspirin treat-
ment, smoking cessation), examination of systemic blood
pressure, ankle blood pressure measurement, ﬁrst-degree
relative with AAA, and an additional abdominal ultra-
sound scanning to secure high-quality videos and pictures
of the AAA.AAAs were detected in 615 patients, 590 of whom had
images that were sufﬁcient for determining the relative
maximal ILT area at the baseline. One hundred and
seventeen of the AAAs were 50 mm in size and were
therefore referred for a computed tomography angiography
and surgical evaluation. The remaining 498 patients were
offered annual follow-up visits. Of these, 416 had under-
gone a follow-up scan at the time of the data analysis and
had sufﬁcient images stored at baseline and at follow-up, as
well as a complete baseline assessment.AAA measurements
As in the VIVA screening study, the systolic longitudinal
anterior to posterior maximal inner diameter was measured
as shown in Fig. 1. The interobserver variability of these
standardised measurements has been estimated to be as
low as 0.86 mm.12
Systolic cross-sectional recordings were also performed
with a semi-automated built-in program (Figs. 2 and 3). The
systolic measurement was determined by a combination of
Figure 3. Same abdominal aortic aneurysm as Fig. 1 in cross-
sectional view, with area measurements using the built-in semi-
automated program to calculate the relative intraluminal
thrombus size.
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through the cineloop. The relative area covered by the
mural thrombus was estimated by a semiautomatic method
using ultrasound to measure the area of the ellipses
adapting an inner ellipse (IA) to the luminal border of the
thrombus and the outer ellipse as the area inside the media
border (OA). The relative thrombus area was then calcu-
lated as ((OAeIA)/OU)  100% (Figs. 2 and 3). When an
AAA was tortuous, the best approximation was used. Only
the transverse section and not the longitudinal section was
used in the area measurements. The cross-sectional area
measurements were later validated by the ﬁrst author, who
reviewed all of the cineloops, ensuring the validity of the
stored data in the VIVA database. The examiner was
personally trained by the most experienced project nurse
on the equipment used in the VIVA trial in how to correctly
perform the same cross-sectional area measurements. To
test the validity of the internal measurement, a small
(n ¼ 25) study was performed, which showed a correlation
coefﬁcient between the ﬁrst and last observations of the
OA, IA, and relative ILT size of 0.99, 0.80, and 0.85,
respectively. The intra-observer variation (2  SD) of the
determination of the relative size of the ILT area was 0.12.
The validation process was blinded for the known size and
growth rate of the AAA.
BlandeAltman plotting (not shown) revealed that the
difference in the observations tended to be highest in the
smaller AAAs, in which the ILT can be difﬁcult to visualise.
STROBE (Strengthening the Reporting of Observational
Studies in Epidemiology) guidelines were followed to
strengthen the reporting of the observational studies in
epidemiology.Figure 4. (A) Proportion of abdominal aortic aneurysms (AAAs)
that contain intraluminal thrombus (ILT) as a function of AAA size.
(B) The mean proportion of the ILT as a function of AAA size.Statistical methods
The categorical variables were coded (No ¼ 0, Yes ¼ 1). The
annual growth rate was estimated by an individual linear
regressions analysis using all of the observations of themaximal systolic inner AP diameter. Linear regression as-
sumes a linear relationship between the size and the
observation time that has been demonstrated multiple
times, most recently by RESCAN.13 Although a mixed-effect
model could have been used, they are more difﬁcult to
interpret and are known not to supply outcomes that differ
from the outcomes of the method that was used in this
study.14 The observations were made at the annual follow-
up visits. The normality of the distributions was tested by
probability plots. The annual growth rate, which was the
dependent variable, was not normally distributed, but
slightly left skewed, which was considered acceptable,
especially as supplemental testing of the inﬂuence of the
transformation did not alter the result. Consequently, the
304 C. Behr-Rasmussen et al.annual growth rate was left untransformed to allow for a
less complicated interpretation. The baseline cross-sectional
relative area of the ILT was used in both the univariate and
the multivariate linear regression analyses. The linear as-
sumptions for the regression analysis were tested by scatter
plots, and the normality of the residuals was tested by
histograms, as well as normal probability plots to determine
the distribution of the residual values.
To identify potential confounders of the size of the mural
thrombus and aneurysm growth rate, the relative area
covered by the ILT and its growth rate were used as
dependent variables for testing the association with po-
tential confounders, such as smoking, daily use of alcohol,
systolic and diastolic blood pressure, ankle brachial index
(ABI), hypertension, and diabetes. Associations with a p-
value <.10 were considered to be potential confounders
and were used in the ﬁnal multivariate analyses in combi-
nation with the non-signiﬁcant, well-known confounders.
To evaluate the potential role of the ILT on the size and
growth rate, size and growth were used as dependent
variables, and the relative area of the ILT was used as the
independent variable with and without adjustment for the
above-mentioned potential confounders of smoking, daily
use of alcohol, systolic and diastolic blood pressure, ABI,
hypertension, peripheral arterial disease, and diabetes.
SPSS version 12.0 (IBM, Armonk, NY, USA) was used for the
statistical analysis.
It is likely that some of the smaller AAAs had a small fresh
thrombus, but were classiﬁed as having no thrombus. All ofTable 1. Baseline characteristics of the 416 abdominal aortic aneurysm
identify potential confounders.
Categorical variables n Relative max
Hereditary predisposition N ¼ 388 .24 (.23)
Y ¼ 28 .30 (.30)
Smoking status N [ 242 .24 (.23)
Y [ 174 .24 (.24)
Diabetes mellitus N [ 372 .25 (.23)
Y [ 44 .22 (.24)
Hypertension N ¼ 191 .25 (.25)
Y ¼ 225 .24 (.24)
Use of statin N ¼ 192 .25 (.23)
Y ¼ 224 .24 (.25)
Use of low-dose aspirin N [ 207 .24 (.23)
Y [ 209 .24 (.24)
Previous acute myocardial infarction N ¼ 325 .24 (.23)
Y ¼ 91 .24 (.23)
Continuous variables
n [ 416
Pearson’s ra
Age .002
BMI e.065
Systolic blood pressure e.043
Diastolic blood pressure .070
Plasma total cholesterol .052
Lowest ABI .016
Initial AAA size .483
Growth rate .198
Note. Suspected confounders and signiﬁcant ﬁndings are highlighted in
mass index; ABI ¼ ankleebrachial index.
a Pearson’s correlation coefﬁcient “r”.the observations where the ILT ¼ 0 were excluded and the
statistical analysis was performed again to investigate the
effect of potential misclassiﬁcations.
RESULTS
The mean maximal systolic diameter of the AAA was
40.6  11.8 mm, the mean observation time was 1.78 years
(range 0.6e3.0 years), and the mean annual growth rate
was 2.55  2.80 mm/year.
Concerning the presence of ILT, 42% of the patients in the
group with AAAs of 30e34 mm had ILT, with a mean rela-
tive size of 12% of the OA. In the group of patients with
AAAs >64 mm, the presence of ILT increased to 100%, with
a mean relative size of 70% of the OA. Thereafter, the
relative size of the ILT decreased in patients with very large
AAAs (Fig. 4A, B).
The baseline characteristics of the patients with AAAs are
shown in Table 1 along with the statistical tests that
attempted to identify the potential confounders. On uni-
variate analysis the relative ILT size (r ¼ .20), aortic diameter
(r ¼ .30), diastolic blood pressure (r ¼ .16), aspirin users
over nonusers (2.42 vs. 3.01 mm/year), and smoking versus
non-smoking (3.16 vs. 2.39 mm/year) was signiﬁcantly
positively associated with the growth rate, whereas the
presence of diabetes mellitus (1.4 vs. 2.8 mm/year) was
signiﬁcantly negatively associated with the growth rate.
The multivariate analysis testing the size of the ILT as an
independent risk factor of aneurysm progression is shown
in Table 2, with adjustment for the potential confounders.(AAA) patients are shown with the statistical tests attempting to
ILT area (SD) p Growth rate in mm/year (SD) p
2.70 (2.53)
.92 2.80 (2.97) .89
2.39 (2.35)
.65 3.16 (2.80) .00
2.83 (2.60)
.35 1.43 (1.92) .01
2.77 (2.59)
.92 2.68 (2.58) .77
2.93 (2.73)
.26 2.55 (2.45) .12
3.01 (2.67)
.76 2.42 (2.46) .033
2.83 (2.63)
.16 2.35 (2.39) .23
p Pearson’s ra p
.98 e.073 .14
.21 e.025 .61
.42 .088 .08
.19 .160 .00
.33 .093 .07
.76 .055 .28
.00 .304 .00
.00
bold. ILT ¼ intraluminal thrombus; N ¼ no; Y ¼ yes; BMI ¼ body
Table 2. Multivariate linear regression analysis using the relative maximum abdominal aortic aneurysm (AAA) area covered by the
intraluminal thrombus (ILT) as the independent predictor, and the AAA growth rate as the dependent variable.
AAA growth rate Unstandardised coefﬁcients Standardised coefﬁcients p 95% CI for B
B SE Beta Lower bound Upper bound
(Constant) 4.131 1.389 .003 6.862 1.401
ILT 0.193 0.085 0.117 .024 0.026 0.361
AAA size 0.101 0.027 0.197 .000 0.049 0.154
Smoking 0.882 0.282 0.154 .002 0.327 1.436
DM 0.944 0.498 0.092 .059 1.924 0.036
PAD 0.466 0.319 0.072 .144 1.092 0.160
DBP 0.028 0.012 0.116 .018 0.005 0.051
Note. Suspected confounders and signiﬁcant ﬁndings are highlighted in bold. CI ¼ conﬁdence interval; Smoking ¼ smoking status;
DM ¼ diabetes mellitus; PAD ¼ peripheral arterial disease; DBP ¼ diastolic blood pressure.
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ciated with the growth rate, as did the initial size of the
AAA, smoking, and diastolic blood pressure. Diabetes was
not found to be signiﬁcantly associated with AAA growth.
The ILT size was heavily confounded, especially by the size
of the AAA, as the crude correlation coefﬁcient between the
ILT size and expansion rate was 0.2, and the adjusted partial
correlation coefﬁcient was only 0.14, but still statistically
signiﬁcant (p ¼ .024).
Calculating the effect size revealed that a relative 10%
increase in maximal relative ILT area was associated with an
increased growth of 0.15 mm/year.
The proportion of the maximum ILT area is depicted as a
function of the growth rate in Fig. 5. The best ﬁtting line
(correlation) is observed to have a slight positive slope. The
160 AAAs without ILT are bundled together in the left part
of the ﬁgure. It is known that some of these AAAs may haveFigure 5. Correlation between relative intraluminal thrombus (ILT)
area and growth rate (r ¼ .2, p < 0.01).been misclassiﬁed because it is difﬁcult to see new fresh
thrombus in a small AAA. When the 160 AAAs were
excluded, the correlation coefﬁcient decreased to 0.11
(p ¼ .08).
DISCUSSION
This observational prospective cohort study reports obser-
vational evidence that suggests that ILTs are involved in the
growth of AAAs independently of the aortic diameter,
among other confounders. After adjusting for potential
confounders, a weak correlation was found between the
initial, relative ILT cross-sectional area and the AAA growth
rate. Furthermore, a positive correlation between the
growth rate and initial AAA size and a positive smoking
status was found. A negative association was found among
diabetics.
As with all observational studies, the classic sources of
bias and study limitations must be considered and
addressed.
Selection bias
The randomised population-based design of the VIVA trial,
with a participation rate of 75% (18,628/25,065), minimises
the probability of selection bias and suggests a high degree
of external generalisability.
Information bias
Information bias would require a systematic bias of the
measurement of the aortic diameter or the estimation of
the relative size of the thrombus.
Measurement bias
All measurements were performed in systole, thus avoiding
increased variation in the measurements.12 The video
sequence was intended to be recorded where the AAA was
at its maximum size, but ILT might be relatively thicker at
another section. This introduces a random error and creates
bias only towards the null hypothesis. Occasionally, the
picture quality complicated the measurement of the IA,
especially in smaller aneurysms with small fresh thrombus
formation; however, the relative ILT area was set to zero if
in doubt. This type of information bias tends to
306 C. Behr-Rasmussen et al.underestimate a correlation. When working with area
measurements the potential errors will be squared, intro-
ducing greater uncertainty. It was noted, in particular, that
the smaller AAAs with smaller ILTs had a higher mean dif-
ference in the BlandeAltman plot (not shown). The poorer
deﬁnition of the lateral walls, due to the direction of the
ultrasound beams, did, at times, complicate the area mea-
surements. The internal validity of the determination of the
relative size of the ILT area was rather high. On the one
hand, variation in the measurements creates a bias towards
the null hypotheses, which makes it more difﬁcult to detect
an association and is more serious when no associations are
found, as this study is an attempt to “prove a concept”
rather than to estimate the true predictive value. On the
other hand, the outer area of an AAA proved to be a quite
valid and reproducible size.
Misclassiﬁcation
Some of the smaller AAAs were most likely misclassiﬁed as a
result of having a small ILT to not having ILT. Of the 416
AAAs, 160 were classiﬁed as not having thrombus. After
excluding the 160 with no ILT, the same analysis was per-
formed on the remaining 256. The result revealed a
decreased and insigniﬁcant correlation. Keeping in mind
that the 160 AAAs comprised more than a third of the total
cohort, the selection alone could reduce the correlation and
make it non-signiﬁcant. However, some of the AAAs may
have been misclassiﬁed, and a 100% correct result based on
the ultrasound images cannot be provided.
The follow-up periods were relatively short, although it is
recognised in epidemiology that longer observation time
can itself cause information bias owing to changes in the
level of the baseline risk factors. However, a short obser-
vation period increases the inﬂuence of the variation of the
measurements and is thus an obvious bias towards the null
hypothesis and cannot explain a signiﬁcant association.
The observational evidence suggests that ILT plays a role
in the growth of an AAA, although it has been difﬁcult to
deliver solid evidence because of the numerous complex
biological and biophysical interactions taking place
simultaneously.
Prior studies, in combination with this study, suggest a
possible beneﬁt for aspirin users compared with non-
users.10 It should be noted that Table 1 clearly shows that
there was no difference in the relative maximum ILT area in
those speciﬁc groups. Aspirin has both an anti-inﬂammatory
and a direct effect on thrombocytes, and it is believed that
both effects are important. In animal studies, platelet in-
hibition impairs the progression of aneurysms containing
ILTs,14 and the use of low-dose aspirin was also associated
with a lower growth rate in this cohort (Table 1). The
experimental trials with non-inﬂammatory antiplatelet
therapy show impairment in the development and growth
of AAAs;15 therefore, the mechanism may not solely be
because of aspirin’s anti-inﬂammatory effects. One of the
largest meta-analyses of smaller AAAs found only minor and
insigniﬁcant effects for cardioprotective drugs.13 Data onstatins were not included in the analysis because all of the
non-users were prescribed statins at the baseline, and only
a few did not follow the regimen; the baseline use was not
associated with AAA or thrombus growth.
The size of the AAA is a heavy confounder because of its
powerful and consistent association with both the size and
relative ILT area, an association that is supported by this
study (Table 1). To counter this, the statistics used seriously
risked an over-adjustment towards the null hypothesis;
despite this, a weak signiﬁcant correlation was still found.
This implies that the ILT could be considered as an inde-
pendent risk factor for AAA growth in this study. It has been
shown in a smaller cohort study that the burden of the
thrombus volume creates a higher risk of cardiovascular
events and a higher risk of accelerated AAA growth.9
Chronic obstructive pulmonary disease (COPD) is re-
ported to be associated with AAA growth,16 but, unfortu-
nately, no robust data on this subject were available. Only
records of COPD medication were available, and these did
not show a trend for its association with growth rate.
A review of the largest screening trials found signiﬁcant
effects in current smokers over non- and prior smokers, a
ﬁnding that is supported by this study, although only data
on current and non-smokers were available.13 There were
no differences in the relative ILT areas when comparing
smokers with non-smokers.
A signiﬁcant beneﬁcial effect in diabetics that appeared
to be protective against AAA growth was found. There has
been speculation about why diabetics demonstrate a slower
AAA growth rate, and some consider glycosylation at a
molecular level to be an important factor.
Taking the risk of over-adjustment in the statistical
method into consideration, the rather weak correlation
found in this study is most likely underestimated, as any
solid bias away from the null hypothesis, except for a small
number of potentially misclassiﬁed AAAs, was not
identiﬁed.
It should be emphasised that the demonstrated positive
association does not say anything about causality and the
demonstrated effect size, and is hardly clinically relevant.
The development and size of the ILT could just as well be
protective. However, believing that the creation of the ILT
does not have a biological purpose, is most likely incorrect,
as there are few, if any, pathophysiological processes known
that do not either harm or protect. The ILT itself could also
be partially harmful and partially protective, theoretically
resulting in poor associations.
The ﬁndings of this study are applicable only to white
men with AAAs aged 65e74 years.
The data were supplied by the randomised VIVA trial,
which yields good external generalisability for this study.
Serious confounding and misclassiﬁcation appears to be
unlikely, as adjustments for the known risk factors of
aneurysm progression were performed. However, in prin-
ciple, residual confounding may be present.
When searching the published literature, no large
human-based prospective analyses investigating ILT and the
natural history of AAA were found. This, to the best of the
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but signiﬁcant, correlation between the relative ILT
maximum area and AAA growth may be underestimated
owing to a statistical over-adjustment for confounders. The
measurement bias of a few small AAAs could inﬂuence this
result, making the correlation smaller.
When dealing with AAAs and ILTs the “chicken and egg”
issue is present. It is still unclear whether large ILTs grow
large AAAs or if it is the other way around. Furthermore,
this study was purely observational, and correlation does
not imply causality.
Whether ILTs are independently responsible for acceler-
ating the growth of AAAs is still unclear, but the weak
correlation found in this study could be another “piece of
the puzzle”. It is believed ILTs are both protective and
harmful, thus making it difﬁcult to ﬁnd solid associations.
This, of course, needs to be backed up by further research.
However, the OA measurement was found to be a valid
and reproducible measurement, and every AAA >64 mm in
this study had ILT.
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